Insulin, Long-Acting
-
Subject Areas on Research
- Basal insulin therapy in type 2 diabetes.
- Comparison of insulin glargine and liraglutide added to oral agents in patients with poorly controlled type 2 diabetes.
- Evaluation of patients at risk for protamine reactions.
- Immunologic reactions to insulin.
- Improved glycemic control enhances the incretin effect in patients with type 2 diabetes.
- Insulin Detemir Is Transported From Blood to Cerebrospinal Fluid and Has Prolonged Central Anorectic Action Relative to NPH Insulin.
- Insulin analogues: new therapies for type 2 diabetes mellitus.
- Long-term outcomes of analogue insulin compared with NPH for patients with type 2 diabetes mellitus.
- One-year sustained glycemic control and weight reduction in type 2 diabetes after addition of liraglutide to metformin followed by insulin detemir according to HbA1c target.
- Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention).
- Revisiting NPH Insulin for Type 2 Diabetes: Is a Step Back the Path Forward?
- Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1C targets.